About the IMS Institute
The IMS Institute comprises researchers who are conducting empirically rigorous, policy-relevant studies to improve the quality and cost-effectiveness of healthcare. The IMS Institute includes members from a variety of disciplines including pharmacy, medicine, law, economics, business, and public policy.
Recently completed projects range from an examination of off-label prescribing among office-based physicians to an analysis of the impact of FDA safety advisories on prescription drug utilization to a study of the influence of patent expiration on the use of antibiotics.
Shaping the Future of Healthcare
Through collaboration with the IMS Institute, researchers and students have access to a broad range of proprietary databases and tools to support independent research, discovery work and requirement development for future funded studies.
IMS LifeLink PharMetrics Plus
- Complete health plan claims information
- 50 million de-identified lives in the U.S.
- Single integrated database, updated monthly
- Available at the three-digit zip code level
- History back to 2009
IMS Prescription Drug Data
- Complete sales trend coverage
- Over 80% coverage for dispensed prescriptions
- National and sub-national views to zip code
- Retail, mail and long-term care channels
- Age, gender, co-pay, method of payment and payer details
IMS Healthcare Relational Services
- Organization and professional reference data
- Includes NPI, AMA, SLN, DEA, and AOA
- Over 600,000 organizations and 1.4 million professionals
- Includes physicians, nurse practioners and physician assistants
- Includes ACOs, IDNs and affiliations
Although the IMS Institute for Healthcare Informatics welcomes proposals examining most aspects of healthcare, projects that are directly relevant to ongoing healthcare reform are of greatest interest. High-priority areas include:
Comparative Effectiveness Research
- Evaluations of which interventions work best, for whom, and under what circumstances
- Analyses of how comparative effectiveness research is reflected in clinical practice
Drug Utilization Trends and Expenditures
- Analysis of national trends in prescription drug utilization and office-based care
- Examination of adoption of new therapies among patient and physician subpopulations
- Evaluation of prescription use and expenditures and factors that influence these trends
- Analysis of association between patient, physician, and health system characteristics and practice patterns
- Establishment of best practices and quality metrics for specific conditions or populations, including for preventive care and screening
- Utilization trends and costs in specific medical areas, such as oncology, cardiovascular disease or rare diseases where orphan drugs or specialty drugs are used
- Investigations of socioeconomic, racial, or ethnic disparities in processes or outcomes of care
Geographic Variations in Care
- Examination of geographic variations in treatments, costs and outcomes
- Ecologic studies examining how geographic variation in prescription use (e.g., antibiotics) is associated with specific outcomes (e.g., antimicrobial resistance)
- Studies using geographic variation in use to infer information regarding disease or treatment prevalence
To learn more about ways that the IMS Institute can support your initiatives, please reach out to our team:
Thank you for your interest. An IMS Health representative will be in touch with you shortly.